Skip to main content
Advertisement
Home

Main navigation

  • Digital Issue Archive
  • Service Directory
  • Awards
  • Advertise
  • Subscribe now

Secondary

  • Travel Insurance
  • Policies & Partnerships
  • Travel Risk Management
  • Travel Trends
  • Hospitals & Healthcare
  • Industry Moves
  • Reviews
International Hospitals & Healthcare Part of the IH&H family
Part of the
IH&H family
International Hospitals & Healthcare

WHO says no to priority vaccination of travellers

Travel Risk Management
27 Jan 2021 | Clara Bullock
Share
Covid-19 vaccine

A panel of experts from the World Health Organization (WHO) said international travellers should not be prioritised for Covid-19 vaccines amid a shortage of the jabs

The WHO's Strategic Advisory Group of Experts on Immunization, known as SAGE, is calling for healthcare workers and the most vulnerable 20 per cent of people in every country to receive Covid-19 jabs before broadening immunisation programmes to other sectors of the population.

"In the current period of very limited vaccine supply, preferential vaccination of international travellers would counter the principle of equity," SAGE said. "Because of this and the lack of evidence that vaccination reduces the risk of transmission, SAGE currently does not recommend Covid-19 vaccination of travellers," it concluded.

High-risk travellers should be included in vaccination programmes

However, it added that people in high-risk groups planning to travel should be included in vaccination programmes.

The development comes amid experts recommending that the Moderna vaccine be given in two doses at an interval of 28 days, which could be extended under exceptional circumstances to 42 days. During a meeting in January, experts discussed the Moderna vaccine, which, like the Pfizer-BioNTech one, uses mRNA technology and is being rolled out in several countries.

Both vaccines require boosters after three to four weeks, but several countries facing limited vaccine supplies have said they will delay administering the second injection so that more people can get the first dose.

A cut in the number of Pfizer-BioNTech vaccines being delivered to Europe have caused vaccination efforts to come to a standstill; and so international travel continues to suffer.

Travel Risk Management
27 Jan 2021
Share

Keep on reading

No results

There are no results available matching your search term.

Why subscribe to ITIJ?

In-depth analysis

In-depth analysis

Unique insights and expert opinions on the latest industry developments

A wider perspective

A wider perspective

Get the global view on the topics that are trending in your region

Breaking news

Breaking news

ITIJ.com has all the latest news relevant to travel insurance and IPMI professionals

Subscribe now
ITIJ IH&H

Footer menu

  • About Us
  • Subscribe
  • Advertise
  • Contact
  • Privacy Policy
  • Terms
  • Voyageur
International Travel & Health Insurance Conferences

Social

  • LinkedIn link
  • Twitter link

© Voyageur Publishing & Events 2026

Close